Newsbenzinga
Collegium Pharmaceutical Reports Q2 2026 Results: Full Earnings Call Transcript
· Published
Article summary
Collegium Pharmaceutical (NASDAQ:COLL) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This content is powered by Benzinga APIs. For comprehensive
An excerpt from the original article.
Comments —
Loading comments…